Grow Your Pharma Business Digitally
Market Place
Post Enquiry
Company
01 AstraZeneca Canada Inc. (2)
Patent
01 2843109 (2)
Product
01 OSIMERTINIB MESYLATE (2)
Dosage
01 TABLET (2)
Exp Date
01 2032-07-25 (2)